Verrica Pharmaceuticals Inc.
(NASDAQ: VRCA)

Verrica Pharmaceuticals, Inc. is a dermatology therapeutics company, which engages in identifying, developing, and commercializing pharmaceutical products for the treatment of skin diseases. Its products include Pipeline VP-102, Pipeline VP-103, and Pipeline VP-315. The company was founded by Matthew Davidson on July 3, 2013 and is headquartered in West Chester, PA.

8.130

-0.290 (-3.44%)
Range 8.000 - 8.600   (7.50%)
Open 8.400
Previous Close 8.420
Bid Price 6.000
Bid Volume 13
Ask Price 6.200
Ask Volume 9
Volume 41,229
Value -
Remark
Delayed prices. Updated at 05 Dec 2025 23:06.
Data powered by
View All Events

Loading Chart...

Please login to view stock data and analysis